Amanote Research
Register
Sign In
Monitoring Soluble Interleukin-2 Receptor Levels in Related and Unrelated Donor Allogeneic Bone Marrow Transplantation
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1701163
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
April 1, 1998
Authors
R Foley
S Couban
I Walker
K Greene
CS Chen
H Messner
J Gauldie
Publisher
Springer Science and Business Media LLC
Related search
Donor T-Lymphocyte Infusion for Unrelated Allogeneic Bone Marrow Transplantation With CD3+ T-Cell-Depleted Graft
Bone Marrow Transplantation
Transplantation
Hematology
Granulocyte Transfusion as a Treatment for Enterococcal Meningoencephalitis After Allogeneic Bone Marrow Transplantation From an Unrelated Donor
Bone Marrow Transplantation
Transplantation
Hematology
Griscelli Syndrome Type 2: Long-Term Follow-Up After Unrelated Donor Bone Marrow Transplantation
Dermatology
Dermatology
Unconditioned Unrelated Donor Bone Marrow Transplantation for IL7Rα- And Artemis-Deficient SCID
Bone Marrow Transplantation
Transplantation
Hematology
Donor-Derived Plasmodium Vivax Infection Following Volunteer Unrelated Bone Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Outcome of Acute Lymphoblastic Leukaemia in Danish Children After Allogeneic Bone Marrow Transplantation. Superior Survival Following Transplantation With Matched Unrelated Donor Grafts
Bone Marrow Transplantation
Transplantation
Hematology
Unrelated Donor Bone Marrow Transplantation for 100 Pediatric Patients: A Single Institute's Experience
Bone Marrow Transplantation
Transplantation
Hematology
Tolerance and Immunity After Sequential Lung and Bone Marrow Transplantation From an Unrelated Cadaveric Donor
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Bone Marrow Transplantation With Interleukin-2-Activated Bone Marrow Followed by Interleukin-2 Therapy for Acute Myeloid Leukemia in Mice
Blood
Biochemistry
Immunology
Cell Biology
Hematology
